Board member Patricia Maryland retires from Encompass Health (NYSE: EHC) for health reasons

Rhea-AI Filing Summary

Encompass Health Corporation reported a change on its board of directors. On September 17, 2025, director Patricia Maryland informed the company that she is retiring from the board for health reasons, effective immediately. The filing notes the board’s appreciation for her insights and contributions, as expressed by chairman Greg Carmichael.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding 8-K Material Events →

Accepted by SEC EDGAR 09/18/2025 - 04:30 PM Learn about SEC filing dates

FAQ

What board change did Encompass Health (EHC) disclose in this 8-K?

Encompass Health disclosed that director Patricia Maryland retired from its board for health reasons, effective immediately on September 17, 2025. The company highlighted her many insights and contributions and expressed appreciation through a statement from board chairman Greg Carmichael.

Why did Encompass Health director Patricia Maryland retire from the EHC board?

Director Patricia Maryland retired from the Encompass Health board for health reasons, as disclosed in the filing. Her decision was communicated to the company on September 17, 2025, and the retirement was effective immediately, with the board formally recognizing her service and contributions.

When was Patricia Maryland’s retirement from Encompass Health’s board effective?

Patricia Maryland’s retirement from Encompass Health’s board was effective immediately on September 17, 2025. The company received her notice that day and promptly disclosed the change, noting her departure under the item covering departures of directors and certain officers.

How did Encompass Health’s board respond to Patricia Maryland’s retirement?

Encompass Health’s board, through chairman Greg Carmichael, expressed gratitude and well wishes to Patricia Maryland. The statement emphasized that it had been a pleasure working with her and acknowledged her many insights and contributions to the company during her board service.

Does the Encompass Health 8-K mention any other management or director changes?

The disclosed information focuses on Patricia Maryland’s immediate retirement from the board for health reasons. Beyond acknowledging her contributions and including standard signature information, the content provided does not describe additional management or director changes at Encompass Health.

false000078516100007851612025-09-172025-09-17

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): September 17, 2025

Encompass Health Corporation

(Exact name of Registrant as specified in its Charter)

Delaware

(State or Other Jurisdiction of Incorporation)

001-10315			63-0860407
(Commission File Number)			(IRS Employer Identification No.)

9001 Liberty Parkway, Birmingham, Alabama 35242

(Address of Principal Executive Offices, Including Zip Code)

(205) 967-7116

(Registrant’s Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.     Emerging growth company   ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock, par value $0.01 per share			EHC			New York Stock Exchange

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Departure of Director.

On September 17, 2025, Patricia Maryland informed Encompass Health Corporation (the “Company”) of her decision to retire for health reasons from the Company’s board of directors, effective immediately. “On behalf of the board of directors of Encompass Health, I wish Pat and her family only the best,” said Greg Carmichael, chairman of the board. “It has been a pleasure working with Pat, and the board is grateful for her many insights and contributions.”

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

ENCOMPASS HEALTH CORPORATION
By:			/S/   Patrick Darby
			Name:			Patrick Darby
			Title:			Executive Vice President, General Counsel and Secretary

Dated: September 18, 2025